Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

[1]  Serum albumin and mortality in the BUPA study. British United Provident Association. , 1994, International journal of epidemiology.

[2]  B. Coull,et al.  Fibrinogen and the Albumin‐Globulin Ratio in Recurrent Stroke , 1993, Stroke.

[3]  E. Barrett-Connor,et al.  Albumin levels as a predictor of mortality in the healthy elderly. , 1992, Journal of clinical epidemiology.

[4]  H. Cohen,et al.  Serum albumin in older persons: relationship with age and health status. , 1992, Journal of clinical epidemiology.

[5]  R. Gillum,et al.  Serum albumin, coronary heart disease, and death. , 1992, American heart journal.

[6]  L H Kuller,et al.  The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. , 1991, American journal of epidemiology.

[7]  L. Chambless,et al.  Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. , 1991, American journal of epidemiology.

[8]  George Howard,et al.  High‐resolution B‐Mode Ultrasound Scanning Methods in the Atherosclerosis Risk in Communities Study (ARIC) , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[9]  A. Shaper,et al.  Albumin, Haemostasis and Cardiovascular Disease , 1991 .

[10]  D. Crook,et al.  Family outbreak of chloramphenicol-ampicillin resistant Haemophilus influenzae type b disease , 1990, The Lancet.

[11]  P. Ducimetiere,et al.  Serum albumin and mortality , 1990, The Lancet.

[12]  C. Mogensen,et al.  Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.

[13]  P. Whincup,et al.  ASSOCIATION BETWEEN SERUM ALBUMIN AND MORTALITY FROM CARDIOVASCULAR DISEASE, CANCER, AND OTHER CAUSES , 1989, The Lancet.

[14]  Aric Invest.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[15]  K. Wu,et al.  ARICHemostasis Study - I. Development of a Blood Collection and Processing System Suitable for Multicenter Hemostatic Studies , 1989, Thrombosis and Haemostasis.

[16]  W. P. Dixon,et al.  BMPD statistical software manual , 1988 .

[17]  C. Jackson,et al.  MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.

[18]  B. Halliwell,et al.  Albumin--an important extracellular antioxidant? , 1988, Biochemical pharmacology.

[19]  B. Ames,et al.  Oxygen radicals and human disease. , 1987, Annals of internal medicine.

[20]  P Pignoli,et al.  Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. , 1986, Circulation.

[21]  W. Kannel,et al.  The prognostic significance of proteinuria: the Framingham study. , 1984, American heart journal.

[22]  W. Gruber,et al.  Reagent for the Enzymatic Determination of Serum Total Triglycerides with Improved Lipolytic Efficiency , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[23]  J. Ziegenhorn,et al.  Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.

[24]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[25]  W. Watson,et al.  Albumin standards and the measurement of serum albumin with bromcresol green. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[26]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[27]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .